Monogram Orthopaedics (MGRM) Competitors $3.29 -0.02 (-0.60%) Closing price 07/11/2025 04:00 PM EasternExtended Trading$3.24 -0.05 (-1.52%) As of 07/11/2025 07:29 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock MGRM vs. TMCI, OM, NPCE, CLPT, NNOX, SKIN, ZIMV, BSGM, SNWV, and DRTSShould you be buying Monogram Orthopaedics stock or one of its competitors? The main competitors of Monogram Orthopaedics include Treace Medical Concepts (TMCI), Outset Medical (OM), NeuroPace (NPCE), ClearPoint Neuro (CLPT), Nano-X Imaging (NNOX), Beauty Health (SKIN), ZimVie (ZIMV), Biosig Technologies (BSGM), Sanuwave Health (SNWV), and Alpha Tau Medical (DRTS). These companies are all part of the "medical equipment" industry. Monogram Orthopaedics vs. Its Competitors Treace Medical Concepts Outset Medical NeuroPace ClearPoint Neuro Nano-X Imaging Beauty Health ZimVie Biosig Technologies Sanuwave Health Alpha Tau Medical Treace Medical Concepts (NASDAQ:TMCI) and Monogram Orthopaedics (NASDAQ:MGRM) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, media sentiment, earnings, dividends, profitability, valuation and risk. Is TMCI or MGRM more profitable? Monogram Orthopaedics has a net margin of 0.00% compared to Treace Medical Concepts' net margin of -25.14%. Treace Medical Concepts' return on equity of -48.69% beat Monogram Orthopaedics' return on equity.Company Net Margins Return on Equity Return on Assets Treace Medical Concepts-25.14% -48.69% -24.59% Monogram Orthopaedics N/A -115.71%-92.75% Do insiders and institutionals have more ownership in TMCI or MGRM? 84.1% of Treace Medical Concepts shares are held by institutional investors. Comparatively, 0.5% of Monogram Orthopaedics shares are held by institutional investors. 27.7% of Treace Medical Concepts shares are held by insiders. Comparatively, 28.1% of Monogram Orthopaedics shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Does the media prefer TMCI or MGRM? In the previous week, Treace Medical Concepts had 2 more articles in the media than Monogram Orthopaedics. MarketBeat recorded 3 mentions for Treace Medical Concepts and 1 mentions for Monogram Orthopaedics. Treace Medical Concepts' average media sentiment score of 0.96 beat Monogram Orthopaedics' score of 0.94 indicating that Treace Medical Concepts is being referred to more favorably in the media. Company Overall Sentiment Treace Medical Concepts Positive Monogram Orthopaedics Positive Which has more volatility & risk, TMCI or MGRM? Treace Medical Concepts has a beta of 0.69, meaning that its stock price is 31% less volatile than the S&P 500. Comparatively, Monogram Orthopaedics has a beta of 0.59, meaning that its stock price is 41% less volatile than the S&P 500. Which has higher earnings and valuation, TMCI or MGRM? Monogram Orthopaedics has lower revenue, but higher earnings than Treace Medical Concepts. Monogram Orthopaedics is trading at a lower price-to-earnings ratio than Treace Medical Concepts, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTreace Medical Concepts$209.36M1.80-$55.74M-$0.85-7.06Monogram Orthopaedics$370K317.35-$16.33M-$0.45-7.31 Do analysts rate TMCI or MGRM? Treace Medical Concepts presently has a consensus price target of $10.16, indicating a potential upside of 69.29%. Monogram Orthopaedics has a consensus price target of $5.40, indicating a potential upside of 64.13%. Given Treace Medical Concepts' higher possible upside, equities research analysts clearly believe Treace Medical Concepts is more favorable than Monogram Orthopaedics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Treace Medical Concepts 0 Sell rating(s) 5 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.29Monogram Orthopaedics 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.50 SummaryTreace Medical Concepts beats Monogram Orthopaedics on 10 of the 17 factors compared between the two stocks. Get Monogram Orthopaedics News Delivered to You Automatically Sign up to receive the latest news and ratings for MGRM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MGRM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MGRM vs. The Competition Export to ExcelMetricMonogram OrthopaedicsMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$118.13M$6.82B$5.60B$9.10BDividend YieldN/A1.25%5.24%4.00%P/E Ratio-7.3124.8927.9620.25Price / Sales317.3549.57429.2099.14Price / CashN/A20.9237.4658.16Price / Book7.834.648.045.49Net Income-$16.33M$174.76M$3.18B$250.27M7 Day Performance13.06%-1.00%3.63%4.75%1 Month Performance25.10%-1.49%4.04%7.64%1 Year Performance45.58%4.27%29.56%16.34% Monogram Orthopaedics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MGRMMonogram Orthopaedics2.558 of 5 stars$3.29-0.6%$5.40+64.1%+48.2%$118.13M$370K-7.3128Gap UpTMCITreace Medical Concepts2.5075 of 5 stars$6.05-2.1%$10.16+67.9%-26.7%$388.66M$209.36M-7.12250Positive NewsOMOutset Medical1.4598 of 5 stars$20.45-2.2%$27.00+32.0%-68.5%$370.40M$113.69M-0.70520Gap DownNPCENeuroPace3.4755 of 5 stars$10.22-1.6%$15.50+51.7%+28.5%$340.78M$79.91M-12.17170CLPTClearPoint Neuro1.9013 of 5 stars$11.80+0.9%$25.00+111.9%+48.8%$327.47M$31.39M-15.53110News CoverageAnalyst DowngradeNNOXNano-X Imaging2.0034 of 5 stars$5.12-3.8%$9.50+85.5%-40.5%$307.38M$11.28M-5.69190Positive NewsSKINBeauty Health0.2539 of 5 stars$2.20-3.5%$1.42-35.6%+3.8%$287.27M$334.30M-5.371,030Gap UpZIMVZimVie2.015 of 5 stars$9.43-8.0%$16.33+73.2%-51.9%$285.43M$449.75M-13.281,770BSGMBiosig Technologies1.9543 of 5 stars$11.55+11.0%$10.00-13.4%+1,119.7%$284.14M$40K0.0050Gap UpHigh Trading VolumeSNWVSanuwave HealthN/A$33.17+4.8%N/AN/A$270.79M$36.19M-7.2840Positive NewsDRTSAlpha Tau Medical3.1831 of 5 stars$3.29+3.8%$8.00+143.2%+39.1%$268.88MN/A-7.1580Positive News Related Companies and Tools Related Companies Treace Medical Concepts Competitors Outset Medical Competitors NeuroPace Competitors ClearPoint Neuro Competitors Nano-X Imaging Competitors Beauty Health Competitors ZimVie Competitors Biosig Technologies Competitors Sanuwave Health Competitors Alpha Tau Medical Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MGRM) was last updated on 7/12/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | Sponsored"I'm risking my reputation on this"Most people think you need thousands to profit from crypto. But this free book exposes how even small inves...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Monogram Orthopaedics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Monogram Orthopaedics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.